Net Income (Loss) Per Share (Tables)

3 Months Ended

Mar. 31, 2026

Schedule of Earnings Per Share, Basic and Diluted

For periods in which the Company reports net losses, basic and diluted net loss per share are the same because potentially dilutive common shares are not assumed to have been issued if their effect is anti-dilutive.


	Three Months Ended March 31,
		2025		2026
Numerator:
Net loss attributable to common stockholders		$	(2,447)	$	(6,646)






Denominator:
Weighted-average common shares outstanding used to calculate net loss per share, basic		94,274,538		96,901,974





Weighted-average common shares outstanding used to calculate net loss per share, diluted		94,274,538		96,901,974

Net loss per share, basic		$	(0.03)	$	(0.07)
Net loss per share, diluted		$	(0.03)	$	(0.07)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following securities were excluded from the computation of diluted net loss per share for the periods presented, due to their anti-dilutive effect:


	Three Months Ended March 31,
		2025	2026

Options to purchase common stock		10,122,309	9,220,829
Unvested RSUs		3,826,545	4,743,439
Unvested PRSUs		—	1,726,737
Purchase rights committed under the ESPP		66,056	139,312

Convertible senior notes		15,929,353	23,477,838

Total		29,944,263	39,308,155